Sodium–glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions

John D'Elia, Alissa Segal, George Bayliss, Larry Weinrauch
  • International Journal of Nephrology and Renovascular Disease, June 2017, Dove Medical Press
  • DOI: 10.2147/ijnrd.s135899

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Larry Weinrauch

In partnership with: